0001209191-19-021305.txt : 20190326 0001209191-19-021305.hdr.sgml : 20190326 20190326160749 ACCESSION NUMBER: 0001209191-19-021305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190325 FILED AS OF DATE: 20190326 DATE AS OF CHANGE: 20190326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zuo William Wei CENTRAL INDEX KEY: 0001427110 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 19705382 MAIL ADDRESS: STREET 1: 3040 POST OAK BLVD STREET 2: SUITE 1110 CITY: HOUSTON STATE: TX ZIP: 77056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-25 0 0001300699 Athenex, Inc. ATNX 0001427110 Zuo William Wei C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 0 1 0 0 President, China Division Common Stock 2019-03-25 4 P 0 1000 12.47 A 1118777 D Stock Option (Right to Buy) 7.50 2025-06-11 Common Stock 120000 120000 D Stock Option (Right to Buy) 11.00 2018-06-13 2027-06-13 Common Stock 1 1 D Stock Option (Right to Buy) 17.30 2028-03-27 Common Stock 25000 25000 D Stock Option (Right to Buy) 13.17 2029-02-28 Common Stock 25000 25000 D This transaction was executed in multiple trades ranging from $12.39 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected. The option vests in three equal installments beginning on June 11, 2016. This option vests in four equal annual installments beginning on March 27, 2019. The option vests in four equal annual installments beginning on February 28, 2020. /s/ Teresa Bair, Attorney-in-Fact 2019-03-26